Complement C3 and high risk of venous thromboembolism: 80517 individuals from the Copenhagen general population study

I Nørgaard, SF Nielsen, BG Nordestgaard - Clinical chemistry, 2016 - academic.oup.com
BACKGROUND Complement activation may contribute to venous thromboembolism,
including deep venous thrombosis and pulmonary embolism. We tested the hypothesis that …
被引用次数：54 相关文章

Complement C3 and High Risk of Venous Thromboembolism: 80517 Individuals from the Copenhagen General Population Study

I Nørgaard, SF Nielsen, BG Nordestgaard - Clinical Chemistry, 2016 - search.proquest.com
Complement activation may contribute to venous thromboembolism, including deep venous
thrombosis and pulmonary embolism. We tested the hypothesis that high complement C3 …

Complement C3 and High Risk of Venous Thromboembolism: 80517 Individuals from the Copenhagen General Population Study

I Nørgaard, SF Nielsen, BG Nordestgaard - Clinical Chemistry, 2016 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> BACKGROUND</jats: title>< jats:
p> Complement activation may contribute to venous thromboembolism, including deep …

Complement C3 and High Risk of Venous Thromboembolism: 80517 Individuals from the Copenhagen General Population Study

I Nørgaard, SF Nielsen, BG Nordestgaard - Clinical Chemistry, 2016 - research.regionh.dk
BACKGROUND: Complement activation may contribute to venous thromboembolism,
including deep venous thrombosis and pulmonary embolism. We tested the hypothesis that …

Complement C3 and High Risk of Venous Thromboembolism: 80517 Individuals from the Copenhagen General Population Study

I Nørgaard, SF Nielsen, B Nordestgaard - comm.ku.dk
BACKGROUND: Complement activation may contribute to venous thromboembolism,
including deep venous thrombosis and pulmonary embolism. We tested the hypothesis that …

Complement C3 and High Risk of Venous Thromboembolism: 80517 Individuals from the Copenhagen General Population Study

I Nørgaard, SF Nielsen, B Nordestgaard - ikm.ku.dk
BACKGROUND: Complement activation may contribute to venous thromboembolism,
including deep venous thrombosis and pulmonary embolism. We tested the hypothesis that …

Complement C3 and High Risk of Venous Thromboembolism: 80517 Individuals from the Copenhagen General Population Study

I Nørgaard, SF Nielsen, BG Nordestgaard - Clinical Chemistry, 2016 - hero.epa.gov
BACKGROUND: Complement activation may contribute to venous thromboembolism,
including deep venous thrombosis and pulmonary embolism. We tested the hypothesis that …

[引用][C] Complement C3 and high risk of venous thromboembolism: 80517 individuals from the Copenhagen General Population Study.

I Norgaard, SF Nielsen, BG Nordestgaard - Clinical Chemistry, 2016 - go.gale.com
Complement C3 and high risk of venous thromboembolism: 80517 individuals from the
Copenhagen General Population Study. - Document - Gale OneFile: Health and Medicine …

Complement C3 and High Risk of Venous Thromboembolism: 80517 Individuals from the Copenhagen General Population Study

I Nørgaard, SF Nielsen… - Clinical …, 2016 - pubmed.ncbi.nlm.nih.gov
Background Complement activation may contribute to venous thromboembolism, including
deep venous thrombosis and pulmonary embolism. We tested the hypothesis that high …

Complement C3 and High Risk of Venous Thromboembolism: 80517 Individuals from the Copenhagen General Population Study.

I Nørgaard, SF Nielsen, BG Nordestgaard - Clinical Chemistry, 2016 - europepmc.org
Background Complement activation may contribute to venous thromboembolism, including
deep venous thrombosis and pulmonary embolism. We tested the hypothesis that high …